Performance assessment of a new G12/A1 antibody-based rapid ELISA using commercially available and gluten-spiked food samples

Eur J Gastroenterol Hepatol. 2024 Apr 1;36(4):416-422. doi: 10.1097/MEG.0000000000002739. Epub 2024 Feb 28.

Abstract

Objective: Food products with <20 mg/kg gluten can be labeled 'gluten-free' according to international regulations. Several antibodies-based ELISAs have been develop to track gluten traces in food products. Among them, R5 and G12 antibody-based ELISAs are the frequently used methods. However, these antibodies have certain limitations. We evaluated the accuracy of G12/A1 antibody-based 'Glutentox ELISA Rapid G12' and compared the results with the current reference method i.e., R5 antibody-based 'Ridascreen R5 ELISA'.

Methods: In the first step, the performance of Glutentox ELISA Rapid G12 kit was inspected by determination of the threshold value i.e., > or <20 mg/kg gluten in different food products. In the second step, quantification accuracy was assessed by quantification of gluten in gluten-free food products spiked with gliadin reference material.

Results: In total 47 food products (naturally and labeled gluten-free, and food with traces of gluten) were included. Of them, 29 products were quantified with <20 mg/kg, and 18 with a low level of gluten by both the kits. Six out of 29 gluten-free products were used for the recovery test at different spike levels. Gluten concentration and mean recovery rates of individual kits showed consistency.

Conclusion: GlutenTox Rapid G12 ELISA could be an appropriate choice for detecting gluten in food products but needs more in-house validation and collaborative tests.

MeSH terms

  • Antibodies
  • Enzyme-Linked Immunosorbent Assay / methods
  • Food Analysis* / methods
  • Gliadin
  • Glutens* / analysis
  • Humans

Substances

  • Glutens
  • Antibodies
  • Gliadin